Health Catalyst (HCAT) Misses Q1 EPS by 22c, Offers Q2 Guidance

Health Catalyst (NASDAQ: HCAT) reported Q1 EPS of ($0.47), $0.22 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $45.1 million versus the consensus estimate of $43.47 million.

Financial Outlook:

Health Catalyst provides forward-looking guidance on total revenue, a GAAP measure, and Adjusted EBITDA, a non-GAAP measure.

For the second-quarter of 2020, we expect:

• Total revenue between $40.8 million and $43.8 million, and
• Adjusted EBITDA between $(7.8) million and $(5.8) million

(Consensus calls for Q2 revenue of $43.3 million)

For earnings history and earnings-related data on Health Catalyst (HCAT) click here.

You May Also Be Interested In

• Equifax (EFX) Tops Q1 EPS by 6c, Misses on Revenue; Offers Guidance
• Wintrust Financial (WTFC) Tops Q1 EPS by 49c
• Liberty Oilfield Services (LBRT) Misses Q1 EPS by 6c, provides outlook